321WELL NEWS - Lifestyle Wellness Benefits Inc

Search
Go to content

Main menu

Bill C-17 Vanessa's Law - Protecting Canadians from Unsafe Drugs Act (Vanessa's Law):

Published by 321WELL in Wellness · 22/3/2015 18:30:32
Tags: C17Vanessa'sLaw

A step in the right direction.

We are not yet at a point in society where citizens are fully protected against corporate posturing and greed.  We are however, getting closer with some protection against the greatest offenders against public safety with the recent Act, C-17 - Vanessa's Law.  Pharmaceutical drugs industry disregard public safety by citing a misleading adage of the "needs of the many outweigh the needs of the few".  Using this lie, pharmaceuticals get away with murder claiming that side effects and death are necessary for future successes in treatment.  

In reality, pharmaceuticals are never interested in successful treatment of disease.  They could never justify curing or eliminating disease as it is not profitable based on
their business model.  To understand this, simply consider their supply and demand market.  Pharmaceuticals supply chemical substitutions of naturally found remedies.  Their market, or demand, consists of sick or dying people.  You may have noticed that a majority of pharmaceutical treatment is dependent on lifetime usage to "manage" the condition.  This is done intentionally as it satisfies the supply and demand model of their industry.  Adding salt to the wound, side effects of these dangerous chemicals require more drugs to offset the reactions.  

There is no question that in extreme catastrophic situations, pharmaceutical drugs can be helpful.
 It is only when we turn a blind eye to the actions of executives, whose only interest are profits, that people are put in danger.  Medical Doctors are so afraid of recommending anything besides pharmaceuticals that their general knowledge base have been reduces to nothing more than drug pushers and thugs.  What exactly could make an adult professional so complacent that they refuse to utilize time honored and proven treatments used by their predecessors, not even 50 years ago?  What could make medical doctors so useless?  Ask yourself these questions before filling the prescription they are so quick to hand over to you or one of your family members.  It should be noted that this does not refer to all medical doctors.  There are still a few that insist on being doctors of good health, not just “medicine”. Surgeons for instance, operate far above pharmaceutical influence and generally consider the life of their patients over anything that a flashy salesmen can offer.

We may not be able to change how pharmaceuticals do business but we can certainly arm ourselves with knowledge and remove their power by stopping their influence in our education systems, medical training and their unique infrastructure that forces deadly chemicals down the throats of unsuspecting people.

Life of Bill C-17

An Act to amend the Food and Drugs Act

The following is a direct copy from the Health Canada webiste.  It may not provide all the solutions but is a very small step in the right direction.

Taken directly from: http://www.hc-sc.gc.ca/dhp-mps/legislation/unsafedrugs-droguesdangereuses-faq-eng.php

What is the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law)?
The Protecting Canadians from Unsafe Drugs Act (Vanessa's Law) amends the Food and Drugs Act. It includes new rules that strengthen the regulation of therapeutic products and improve the reporting of adverse reactions by healthcare institutions. As well, these measures are intended to improve Health Canada’s ability to collect post-market safety information and take appropriate action when a serious health risk is identified.
The law is named after Vanessa Young, daughter of the Member of Parliament from Oakville.
Where can I find a copy of this Act?
Protecting Canadians from Unsafe Drugs Act (Vanessa's Law) can be found on the Parliament of Canada website.
What products are affected by this Act?
The Act applies to therapeutic products including prescription and over-the-counter drugs, vaccines, gene therapies, cells, tissues and organs, and medical devices.
The amendments brought to the Food and Drugs Act by Vanessa's law do not apply to natural health products, which continue to be regulated under the existing Natural Health Product Regulations (NHPR) of the Food and Drugs Act.
What are the key parts of the new legislation?
The new legislation will update the law that apply to drugs and medical devices to increase patient safety in key areas of concern and will enable the Government to:
Require strong surveillance, including mandatory adverse drug reaction reporting by healthcare institutions;
Recall unsafe therapeutic products;
Impose tough new penalties for unsafe products, including jail time and new fines of up to $5 million per day instead of the current $5,000;
Provide the courts with discretion to impose even stronger fines if violations were caused intentionally;
Compel drug companies to revise labels to clearly reflect health risk information, including potential updates for health warnings for children; and
Compel drug companies to do further testing on a product, including when issues are identified with certain at-risk populations such as children.
How will this Act benefit Canadians?
The Act increases patient safety in Canada by improving Health Canada's ability to collect safety information on marketed therapeutic products.
The Act also allows Health Canada to take quick and appropriate action when a serious health risk is identified, such as ordering a product recall or requiring a label change/package modification to make new safety information available to patients and consumers.
Fines and penalties are increased to better reflect the seriousness of the violation.
In addition to these measures, the Act was also amended by the House of Commons Standing Committee on Health to include new transparency authorities related to clinical trial registration, Health Canada’s regulatory decisions, and disclosure of confidential business information.
Together, these changes will lead to improved patient safety and better health outcomes for Canadians, including vulnerable populations such as children, seniors, and pregnant or nursing women.
The Act enables Health Canada to continue strengthening its
Regulatory Transparency and Openness Framework that was announced in April, 2014 by the Minister of Health. The Framework commits Health Canada to a set of concrete initiatives that would make easy to understand regulatory health and safety information more available to Canadians. With this information, Canadians can make well-informed decisions concerning their health and that of their families.
What else will the Act do?
The primary focus of the legislation is to improve patient safety. The Act also provides a new authority to reference technical standards, lists, guidelines or other documents in regulations. Currently, the contents of these kinds of documents or lists are found within the regulations, and can only be changed with a regulatory amendment. The new authority will help to reduce red tape and allow science-based decisions to be made more rapidly.
How does the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law) compare with legislation in other countries?
Canada has one of the safest and most rigorous drug and medical device approval systems in the world. However, the Food and Drugs Act has not been updated in over 50 years. Science and medicine have evolved considerably in those 50 years, and there has been significant progress internationally to improve patient safety through enhanced regulatory oversight of products on the market.
Implementation of this Act will improve patient safety and health outcomes by providing Health Canada with the post-market authorities it needs to better understand the benefits and harms associated with a therapeutic product.
When will the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law) become enforceable?
Some of the new powers in the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law), come into force immediately upon Royal Assent. These include:
Ability to recall unsafe therapeutic products
Ability to impose tougher fines and penalties
Ability to direct label change/modification, and
Ability to seek an injunction
Other changes to the Food and Drugs Act cannot come into force until supporting regulations are published. There will be an opportunity for Canadians to comment on the supporting regulations as part of the regulatory development process.
Several regulatory frameworks, which are linked to the Act, are being developed. These are being developed as part of the
Regulatory Roadmap for Health Products and Food.